Výsledky vyhledávání - "Malgorzata, Sladek"

Akademický článek

Infliximab Therapy Could Decrease the Risk of the Development of Thyroid Disorders in Pediatric Patients With Crohn's Disease

Autor: Aleksandra Furtak, Anna Maria Wedrychowicz, Malgorzata Sladek, Andrzej Wedrychowicz, Krzysztof Fyderek, Jerzy Starzyk

Publikováno v: Frontiers in Endocrinology, Vol 11 (2020)

Autoimmune diseases, including autoimmune thyroid diseases (AITDs), may be associated with Crohn's disease (CD). Taking into consideration the role of tumor necrosis factor alpha (TNF-alpha) in the immune-mediated inflammation that underlies both dis

Externí odkaz: https://doaj.org/article/91eca2627f4e4307bd4123a0df22326d

Zobrazit plný text záznamu

Orofacial Granulomatosis Associated with Crohn's Disease

Autor: Konstantinos H. Katsanos, Konstantinos Karmiris, Nanne K. H. de Boer, Frank Phillips, Pierre Ellul, Bram Verstockt, Malgorzata Sladek, Tamás Molnár, Ecco Confer Investigators, Ahmad Albshesh, Daniel Bergemalm, Carl Erikson

Publikováno v: Journal of Crohn's & colitis, 16(3), 430-435. Elsevier
Phillips, F, Verstockt, B, Sladek, M, de Boer, N, Katsanos, K, Karmiris, K, Albshesh, A, Erikson, C, Bergemalm, D, Molnar, T & Ellul, P 2022, ' Orofacial Granulomatosis Associated with Crohn's Disease : a Multicentre Case Series ', Journal of Crohn's & colitis, vol. 16, no. 3, pp. 430-435 . https://doi.org/10.1093/ecco-jcc/jjab158

BackgroundOrofacial granulomatosis [OFG] is a rare syndrome that may be associated with Crohn’s disease [CD]. We aimed to characterise this relationship and the management options in the biologic era.MethodsThis multicentre case series was supporte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c5e514bcfd65be529bc194fea4bd2df
https://doi.org/10.1093/ecco-jcc/jjab158

Zobrazit plný text záznamu

Plný text ve formátu HTML

Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn's disease : a randomised controlled trial

Autor: Jorge Amil Dias, Baruch Yerushalmi, Dan Turner, Gigi Veereman Wauters, Athos Bousvaros, G Abitbol, Rotem Sigall Boneh, Mona Boaz, Eytan Wine, J. Kierkus, Malgorzata Sladek, Johanna C. Escher, Arie Levine, Michal Kori, Ron Shaoul

Publikováno v: Gut, 68(2), 239-247. BMJ Publishing Group

ObjectiveCrohn’s disease (CD) pathogenesis associated with dysbiosis and presence of pathobionts in the lumen, intracellular compartments and epithelial biofilms. Azithromycin is active in all three compartments. Our goal was to evaluate if azithro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9cf84cc123a7c26f305659b657667d5
https://doi.org/10.1136/gutjnl-2017-315199

Zobrazit plný text záznamu

Autor: Harland S. Winter, Jorge Amil Dias, Claudio Romano, Malgorzata Sladek, Arnold G. Vulto, Victorien M. Wolters, Paolo Lionetti, Amit Assa, Gábor Veres, Almuthe C. Hauer, Caterina Strisciuglio, Lissy de Ridder, Richard K. Russell, Daniela Knafelz, Jiri Bronsky, Nadeem A. Afzal

Publikováno v: Journal of Pediatric Gastroenterology and Nutrition, 68(1), 144-153. Lippincott Williams & Wilkins
Journal of Pediatric Gastroenterology and Nutrition, 68(1), 144. Lippincott Williams and Wilkins

Biologic therapies have changed the outcome of both adult and pediatric patients with Inflammatory Bowel Disease (IBD). In September 2013, the first biosimilar of infliximab was introduced into the pharmaceutical market. In 2015, a first position pap

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b212099309df36850facd11b2c4f118
https://doi.org/10.1097/mpg.0000000000002141

Zobrazit plný text záznamu

Induction and maintenance infliximab therapy in children withmoderate to severe ulcerative colitis: Retrospective, multicenter study

Autor: Magdalena Kacperska, Anna Szaflarska-Popławska, Agata Wasilewska, Grażyna Czaja-Bulsa, Barbara Iwańczak, Sabina Więcek, Mariusz Szczepanik, Malgorzata Sladek, Bartosz Korczowski, Edyta Sienkiewicz, Franciszek Iwańczak, Jolanta Maślana, Józef Ryżko, Piotr Jankowski

Publikováno v: Advances in Clinical and Experimental Medicine. 26:57-61

BACKGROUND Registration of infliximab in Poland has increased chances to induce clinical remission and mucosal healing in the severe form of pediatric Crohn's disease. OBJECTIVES The aim of this retrospective study was to assess the results and safet

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e2ded3c74db98742d592e253bfd7f1c2
https://doi.org/10.17219/acem/35802

Zobrazit plný text záznamu

Treatment-Specific Composition of the Gut Microbiota Is Associated With Disease Remission in a Pediatric Crohn's Disease Cohort

Autor: Daniel D. Sprockett, Baruch Yerushalmi, Natalie Fischer, Athos Bousvaros, Rotem Sigall Boneh, J. Kierkus, Scott B. Snapper, Jorge Amil Dias, Eytan Wine, David A. Relman, Susan Holmes, Ron Shaoul, Dan Turner, Johanna C. Escher, Malgorzata Sladek, Michal Kori, Arie Levine

Publikováno v: Inflammatory Bowel Diseases, 25(12), 1927-1938. Oxford University Press
Inflamm Bowel Dis

Background The beneficial effects of antibiotics in Crohn’s disease (CD) depend in part on the gut microbiota but are inadequately understood. We investigated the impact of metronidazole (MET) and metronidazole plus azithromycin (MET+AZ) on the mic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efe296ff8c5ec076b2f5b7342769ef13
https://pure.eur.nl/en/publications/f16c5173-0694-4c6d-9f60-ccc4c6d13d6a

Zobrazit plný text záznamu

Vaccinations and immunization status in pediatric inflammatory bowel disease: a multicenter study from the pediatric IBD Porto Group of the ESPGHAN

Autor: Malgorzata Sladek, Gábor Veres, Marina Aloi, Massimo Martinelli, Tereza Lerchova, Iva Hojsak, Caterina Strisciuglio, Víctor Manuel Navas-López, Claudio Romano, Vaidotas Urbonas, F.P. Giugliano, Aleksandra Banaszkiewicz, Daniela Elena Serban, Ruta Kucinskiene, Erasmo Miele, Amit Assa

Publikováno v: Inflammatory bowel diseases, 26(9), 1407-1414. John Wiley and Sons Inc.

BackgroundVaccine-preventable diseases and opportunistic infections in pediatric inflammatory bowel disease (IBD) are increasingly recognized issues. The aims of this study were to evaluate vaccinations, immunization status, and consequent therapeuti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43ea75dd01a8a06bf5ab46b92dcd3d5e
http://hdl.handle.net/11570/3147640

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání